the Study to Evaluate the Safety of UB-421 in Combination With Antiretroviral Therapy (ART) and the Efficacy in Reduction of HIV Viral Load and Proviral DNA as Compared to ART Alone in ART-experienced Viremic HIV-1 Patients

NCT04041362 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The study will not be submitted to authority for IND application.

Conditions

HIV-1 Infection

Interventions

BIOLOGICAL: UB-421
OTHER: Antiretroviral Therapy (ART)

Sponsor

United BioPharma